Their own release documentation, the minimal amount available to the public, showed criteria for not releasing. The death rate during the initial trial would have halted ANY distribution of this injection. I wont even get into all the conversations around critical fails with the GMP aspect of this gene therapy.
Their own release documentation, the minimal amount available to the public, showed criteria for not releasing. The death rate during the initial trial would have halted ANY distribution of this injection. I wont even get into all the conversations around critical fails with the GMP aspect of this gene therapy.